1. Medtech Insight
  2. >>Geography
  3. >>Europe

Evidence Lacking On How Cyber Attacks Impact Patients

More Research Is Needed

 
• By Amanda Maxwell

Without new tools, cyber security risks related to the increasing digitization of healthcare will remain unmonitored and under-researched, a new report warns.  

cybercrime%20shutterstock_573212500.jpg

The EU needs a robust framework and tools to evaluate causal connections between cyber incidents and adverse health effects to monitor and research the rising risk of cyber incidents in an increasingly digitized healthcare environment.

Without these tools and more harmonized reporting, the sector will remain

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Europe

More from Geography

Faster Device Certification Among Keys To Unlocking Innovation In EU MedTech Sector

 
• By Amanda Maxwell

While MedTech Europe sharpens its focus on what the EU most urgently needs to advance the medtech market in four targeted measures, the European Commission has also unveiled four priorities for 2025.

Will NICE’s New Medtech Evaluation Plans Hit the Target for Patients and Industry?

 
• By Ashley Yeo

One year after the UK mooted the Rules-Based Pathway to give medtechs clarity on what can be expected from an evaluation, the devices industry says UK healthtech assessment and adoption processes are still failing to meet the needs of innovators and patients.

The Value Of Consumer Wearables Within The Clinic Is Currently Unknown, Says Cardiologist

 
• By Natasha Barrow

“It’s quite likely [consumer wearable manufacturers] are changing the sensitivity and specificity based on consumer feedback, but not for medical reasons,” said Dipak Kotecha, a University of Birmingham professor of cardiology. Often, self-reported performance evidence from manufacturers is “low quality and biased.”